MiMedx Group Announces Commercial Launch Of HELIOGEN Fibrillar Collagen Matrix, A Particulate Xenograft Product For Complex Surgical Wounds; HELIOGEN Contains Type I And Type III Collagen And Mimics Native Structural Connective Tissue
MiMedx Group Announces Commercial Launch Of HELIOGEN Fibrillar Collagen Matrix, A Particulate Xenograft Product For Complex Surgical Wounds; HELIOGEN Contains Type I And Type III Collagen And Mimics Native Structural Connective Tissue
MiMedx集團宣佈商業推出HELIOGEN微纖維膠原基質,這是一種複雜外科創口用的xenograft產品;HELIOGEN含有I型和III型膠原蛋白,可以模擬天然結構連接組織。
MiMedx Group Announces Commercial Launch Of HELIOGEN Fibrillar Collagen Matrix, A Particulate Xenograft Product For Complex Surgical Wounds; HELIOGEN Contains Type I And Type III Collagen And Mimics Native Structural Connective Tissue
MiMedx集團宣佈商業推出HELIOGEN微纖維膠原基質,這是一種複雜外科創口用的xenograft產品;HELIOGEN含有I型和III型膠原蛋白,可以模擬天然結構連接組織。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。